Hawaii 2026

HCR 134

URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

Open original source Back to bills

Official record

Measure details

Jurisdiction: Hawaii
Session: 2026
Chamber: lower
Classification: concurrent resolution
Subjects: Board of Pharmacy, Budesonide, Health, Nebulizer, Over-the-Counter Medication
Introduced / first action: 2026-03-16 00:00:00

Actions

2026-03-18 00:00:00
Referred to HLT, CPC, referral sheet 19
referral-committee
2026-03-16 00:00:00
Offered
introduction

Documents and versions

Official links

HCR134
HCR134

Recorded votes

Roll calls

No recorded vote is supplied for this bill.

When supplied by the API

Related measures

HR 126: companion

Traceable provenance

Source records

Open States record or bulk source
Original state source

Provider updated: 2026-10-27 06:54:01. Locally fetched: 2026-10-30 00:37:07.